![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Wockhardt to Provide COVID-19 Vaccine Manufacturing to the UK
Wockhardt to Provide COVID-19 Vaccine Manufacturing to the UK
![Vaccine needle](https://www.fdanews.com/ext/resources/test/Drug-Images4/Vaccine-needle-bottle.gif?t=1596243581&width=430)
August 4, 2020
India-based drugmaker Wockhardt will provide fill-and-finish services for millions of doses of a COVID-19 vaccine under a new contract with the UK government.
In the 18-month deal, the UK government has reserved exclusive manufacturing capacity from Wockhardt subsidiary CP Pharmaceuticals for fill-and-finish production of multiple vaccines, including AstraZeneca’s and Oxford University’s promising vaccine candidate AZD1222.
The company will begin production next month at its facility in North Wales.
Upcoming Events
-
21Oct